For patients with Crohn's disease, these effects could potentially: Mimic or mask disease flare symptoms, making it difficult to distinguish medication side effects from disease activity Exacerbate existing gastrointestinal symptoms, reducing quality of life Complicate nutritional management and absorption of other medications Increase the risk of dehydration, particularly if diarrhoea is already present Serious risks associated with GLP-1 receptor agonists include: Acute pancreatitis : Patients should be advised to seek immediate medical attention if they experience severe, persistent abdominal pain radiating to the back, as this may indicate pancreatitis
It isn't the drug company's choice it's a federal rule meant to avoid conflicts of interest, which is why discount offers always note they aren't valid for Medicare or Medicaid beneficiaries
Your team will decide on the best injection site for you
Consult a doctor if you are pregnant or taking any medication
Semaglutide, a GLP-1 receptor agonist originally developed for diabetes management, has become one of the most effective weight loss medications available today
Early reporting stops problems from becoming worse